Table 3.
Microbiological characteristics of infected patients (152)
| Characteristics | Patients n (%) | P Value |
|---|---|---|
| Antibiotic prophylaxis | ||
| Yes | 98 (64.4) | <0.001 |
| No | 54 (35.6) | |
| Days to infection | ||
| ⩽15 days | 113 (74.3) | <0.001 |
| ⩾15 days | 39 (25.7) | |
| Wound culture | ||
| Done | 148 (97.4) | <0.001 |
| Positive growth | 112 (75.7) | |
| No growth | 36 (24.3) | |
| Organisms isolated (n = 144) | <0.001 | |
| No MDRO (102) | ||
| MDRO (42) | ||
| MRSA | 34 (30.3) | |
| K. pneumonia (ESBL+) | 3 (6.2) | |
| E. coli (ESBL+) | 3 (6.2) | |
| P. mirabilis (ESBL+) | 1 (0.9) | |
| A. baumannii | 1 (0.9) |
MDRO, multi-drug resistant organism; MRSA, methicillin-resistant Staphylococcus aureus; ESBL+, extended-spectrum beta lactamase positive.